Erts Wealth Advisors, LLC Novartis Ag Transaction History

Erts Wealth Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $181,981 - $220,116	-2,331 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $109,821 - $121,667	-1,337 Reduced 36.45%	2,331 $203,000
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $27,435 - $30,882	-339 Reduced 8.46%	3,668 $320,000
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $706 - $990	10 Added 0.25%	4,007 $330,000
Q4 2019 Feb 19, 2020	SELL	$84.35 - $95.37 $229,516 - $259,501	-2,721 Reduced 40.5%	3,997 $378,000
Q4 2019 Feb 12, 2020	BUY	$84.35 - $95.37 $175,532 - $198,464	2,081 Added 44.88%	6,718 $576,000
Q3 2019 Nov 05, 2019	SELL	$85.54 - $94.26 $157,479 - $173,532	-1,841 Reduced 28.42%	4,637 $403,000
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $18,076 - $20,676	-240 Reduced 3.57%	6,478 $623,000
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $494,847 - $551,010	6,718 New	6,718 $576,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Erts Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Erts Wealth Advisors, LLC with notifications on news.